Raymond F. Vennare - 28 Nov 2025 Form 4 Insider Report for Predictive Oncology Inc. (POAI)

Role: Chief Executive Officer, Director
Signature: /s/ Josh Blacher, Attorney-in-Fact
Issuer symbol: POAI
Transactions as of: 28 Nov 2025
Net transactions value: -$14,001
Form type: 4
Filing time: 02 Dec 2025, 18:03:38 UTC
Previous filing: 11 Sep 2025
Next filing: 09 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Vennare Raymond F	Chief Executive Officer, Director	C/O PREDICTIVE ONCOLOGY INC., 91 43RD STREET, SUITE 110, PITTSBURGH	/s/ Josh Blacher, Attorney-in-Fact	02 Dec 2025	0001882090

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	POAI	Common Stock	Tax liability	$14,001	-2,373	-27%	$5.90	6,418	28 Nov 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On September 9, 2025, Reporting Person was granted 8,331 restricted stock units ("RSUs"). Each RSU represented the right to receive one share of common stock upon vesting. The RSUs vested in full on October 31, 2025 and were settled on November 28, 2025. 2,373 shares of common stock were withheld by the Issuer on November 28, 2025 to cover withholding tax, in accordance with the Restricted Stock Unit Award Agreement between Reporting Person and the Company.

Content

On September 9, 2025, Reporting Person was granted 8,331 restricted stock units ("RSUs"). Each RSU represented the right to receive one share of common stock upon vesting. The RSUs vested in full on October 31, 2025 and were settled on November 28, 2025. 2,373 shares of common stock were withheld by the Issuer on November 28, 2025 to cover withholding tax, in accordance with the Restricted Stock Unit Award Agreement between Reporting Person and the Company.